Tyra Biosciences Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Tyra Biosciences Inc.
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Carlsbad
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
TYRA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001863127
EIN
83-1476348

Board of directors

Follow this board

Chief executives

Todd Harris · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

9 of this board's directors also sit on 31 other boards.

Network of Tyra Biosciences Inc.'s board connections Bicara Therapeutics Inc. Bicara Therapeutics In... Jade Biosciences Inc. Jade Biosciences Inc. Janux Therapeutics Inc. Janux Therapeutics Inc... Parabilis Medicines Inc. Parabilis Medicines In... PepGen Inc. PepGen Inc. Septerna Inc. Septerna Inc. SpyGlass Pharma Inc. SpyGlass Pharma Inc. ARS Pharmaceuticals Inc. ARS Pharmaceuticals In... Acrivon Therapeutics Inc. Acrivon Therapeutics I... Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals... Artiva Biotherapeutics Inc. Artiva Biotherapeutics... Black Diamond Therapeutics Inc. Black Diamond Therapeu... Climb Bio Inc. Climb Bio Inc. Evommune Inc. Evommune Inc. Freenome Inc. Freenome Inc. Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Habib J. Dable Habib J. Dable Jake Simson Jake Simson Peter Kolchinsky Peter Kolchinsky Rajeev M. Shah Rajeev M. Shah Tyra Biosciences Inc.
Shared director Other board Same sector +15 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$20,000
1 purchase by 1 insider
Sold, last 12 months
$10,589,028
14 sales by 3 insiders
Date Insider Transaction Shares Price Value
Sep 15, 2026 Fuhrman Alan Officer (Chief Financial Officer) Grant or award +951 $9.13 $8,682
Sep 15, 2026 Todd Harris Director, Officer (President and CEO) Grant or award +864 $9.13 $7,887
Sep 15, 2026 Rueb Yuliya Officer (Vice President, Finance (PAO)) Grant or award +2,925 $9.13 $26,702
Sep 9, 2026 Rehan Verjee Director Open-market purchase +972 $20.58 $20,000
May 5, 2026 Warner Douglas J Officer (Chief Medical Officer) Grant or award +25,000 — —
May 5, 2026 Fuhrman Alan Officer (Chief Financial Officer) Grant or award +20,000 — —
May 5, 2026 Todd Harris Director, Officer (President and CEO) Grant or award +79,000 — —
May 5, 2026 Ashar Bhavesh Officer (Chief Operating Officer) Grant or award +15,013 — —
May 5, 2026 Rueb Yuliya Officer (Vice President, Finance (PAO)) Grant or award +8,333 — —
Mar 26, 2026 Gilla Kaplan Director Option exercise −53,172 $2.25 $119,637
Mar 26, 2026 Gilla Kaplan Director Sold back to the company −53,172 $37.75 $2,007,243
Mar 25, 2026 Gilla Kaplan Director Option exercise +14,295 $2.25 $32,164
Mar 25, 2026 Gilla Kaplan Director Open-market sale −14,295 $36.97 $528,486
Mar 13, 2026 Fuhrman Alan Officer (Chief Financial Officer) Grant or award +1,376 $9.13 $12,563
Mar 13, 2026 Todd Harris Director, Officer (President and CEO) Grant or award +1,463 $9.13 $13,357

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.